-56.4%
FICO vs GSK
+14.9%
-71.3%
-67.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.2% | +5.0% | -8.3% | -4.5% |
| 7D | +0.4% | +4.9% | -4.5% | -0.9% |
| 30D | +1.7% | +9.9% | -8.2% | -1.1% |
| 3M | -33.0% | +0.2% | -33.2% | -33.0% |
| 6M | -33.9% | +2.3% | -36.2% | -33.7% |
| YTD | -58.5% | +7.1% | -65.6% | -59.8% |
| 1Y | -56.4% | +13.1% | -69.5% | -58.9% |
| All | -56.4% | +14.9% | -71.3% | -58.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling